Financhill
Back

Novo Nordisk AS Stock Predictions

Novo Nordisk AS Stock Forecast

  • Over the next 52 weeks, Novo Nordisk AS has on average historically risen by 22.8% based on the past 16 years of stock performance.
  • Novo Nordisk AS has risen higher in 13 of those 16 years over the subsequent 52-week period, corresponding to a historical accuracy of 81.25%
  • Is Novo Nordisk AS Stock Undervalued?
    The current Novo Nordisk AS [NONOF] share price is $63.14. The Score for NONOF is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
  • NONOF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Novo Nordisk AS Stock Go Up Next Year?

  • Over the next 52 weeks, Novo Nordisk AS has on average historically risen by 22.8% based on the past 16 years of stock performance.

Novo Nordisk AS Stock Rating

Sell
18
Novo Nordisk AS (NONOF) is a Sell

Is Novo Nordisk AS overpriced?

  • Novo Nordisk AS has risen higher in 13 of those 16 years over the subsequent 52-week period, corresponding to a historical accuracy of 81.25%

Novo Nordisk AS Stock Price History

Is NONOF stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
OTCM
Country:
Denmark
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
novonordisk.com

52-Week Data

52-Week High:
149.55
52-Week Low:
60.67

Prediction Charts

Market Cap:
285.3B
Price in USD:
63.14
Volume:
39K
Beta:
0.55

Technical Analysis

SMA50:
80.63
SMA100:
89.05
SMA200:
108.99
52-Wk Change:
-49%

Stock Predictions

  • Is Novo Nordisk AS stock public?
    Yes, Novo Nordisk AS is a publicly traded company.
  • What is the Novo Nordisk AS stock quote today?
    The Novo Nordisk AS stock price is 63.14 USD today.
  • How to buy Novo Nordisk AS stock online?
    You can buy Novo Nordisk AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-19 80.11 79.88 80.58 78.80
Mar-20 79.62 78.46 79.78 78.24
Mar-21 75.65 76.90 77.54 75.38
Mar-24 75.38 74.68 76.02 74.61
Mar-25 75.38 73.35 75.99 73.35
Mar-26 72.95 71.49 73.91 70.85
Mar-27 69.51 69.78 70.64 69.25
Mar-28 69.78 69.30 70.17 68.03
Mar-31 67.78 68.96 69.50 66.88
Apr-1 69.51 67.56 70.35 67.25
Apr-2 67.96 68.22 68.75 67.34
Apr-3 67.99 67.14 68.68 66.90
Apr-4 64.85 62.16 65.66 61.40
Apr-7 61.29 63.14 64.68 60.67

Novo Nordisk AS Earnings

Novo Nordisk AS Earnings Report: Per Share Novo Nordisk AS Earnings Q1 Q2 Q3 and Q4 last year and next year.

Novo Nordisk AS Forecast Revenue Growth

Novo Nordisk AS Stock Analysis: Historical quarterly revenues per share for Novo Nordisk AS and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.00 per share.

* Novo Nordisk AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.